Your analogy is shallow and ill informed.
In your own example you speak of other drugs that are being used to treat COVID-19. That is correct - OTHER DRUGS TREATING COVID VERSUS IVERMECTIN.
Can you please tell me what drug(s) is currently treating Chronic Cough?
Can you tell me what drug(s) is currently treating Ischemic Stroke?
Can you tell me what drug(s) is currently treating Idiopathic Pulmonary Fibrosis?
Can you tell me what drug(s) is currently treating Small Cell Lung Cancer?
Can you tell me what drug(s) is currently treating Pancreatic Cancer?
And the list goes on and on and on...
Can you tell me the effectiveness of any of the drugs found in the above questions?
Can you tell me what Orphan Drug Designation means?
Can you tell me where the psychedelic drug DMT comes from?
Can you tell me how many Billions of dollars have been poured into all the current psychedelic drugs that have recently been listed at Nasdaq and NYSE?
Can you tell me how GH Research has a market cap of 1.25B USD with only DMT in it's portfolio @ Phase 2 of the clinical trial process?
Let me guess...you're one of the clan members from over at Arch?
As if I haven't spent enough time debunking their wild and outlandishly ill informed theories about all things Algernon.
You are here barking up the wrong tree with the wrong information.
Your rant sounds more like one of those far right wing nutjobs still ranting about taking horse pills to treat COVID-19.
I'd also bet you have some chips in the Mining arena?
The very type of investor the CEO @ Algernopn said is basically dumber than a box of rocks when it comes to biotech.
You and others from Arch continue to prove that's not just a theory but a fact and it's only been a day since the CEO made the comment.
rotflmao
My best suggestion to you is to end this nonsense you are bringing to this message board.
You simply don't know what you don't know.
However, as to your "Ivermectin" please read this article very slowly and absorb what it says about Ivermectin and Repurposed drugs in general.
Repurposing drugs for treatment of COVID-19 - The Lancet Respiratory Medicine
The clinical trials being run around the globe 24/7/365 utilizing Repurposed Drugs are not being done for free.
There is a cost associated with every drug in use.
There's also a potential trail of money leading back to whatever companies in the Repurposed Drugs space can get a hit with COVID-19.
We are back to talking about MACROECONOMICS versus microeconomics (see posts @ Arch).
Lastly, can you tell me in what country other than Japan is Ifenprodil sold to treat any disease?
I'm not talking about Ifenprodil being sold for research purposes.
I'm talking about it being sold to treat a specific disease.
Name the countries here ________I'll wait.
Outside of Japan, name the countries where Ifenprodil is licensed to be sold ________ I'll wait.
The bottom line is Algernon will do just fine @ Nasdaq.
The primary reason is it won't have to rely on Primates (Cave Dwellers) with short attention spans and short pockets clamoring for their next little pennies flip.
I'd much rather prefer to take my chances with real world stock analysts making their recommendations of what the future holds for Algernon's portfolio of repurposed Drugs.
Trying to explain basic facts to CSE/OTC investors over and over and over again is a waste of time and energy.
Bring On DMT - Stroke.
Bring On DMT - Small Cell Lung Cancer.
Bring On Ifenprodil - Chronic Cough.
Bring On NASDAQ
Matthew 8:26